Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy

PaperCitations, authors & open-access status

Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 155 citations, 2019 year and closed oa status.

155
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Chun Wang
Author
CRISPR and Genetic Engineering
Topic
CRISPR and Genetic Engineering
Topic
CAR-T cell therapy research
Topic
Advanced biosensing and bioanalysis techniques
Topic
470M+ articles · free account